Conotoxia Invest Review 2026

Conotoxia Invest is a former Cyprus-regulated retail forex/CFD service of Conotoxia Ltd whose CIF licence 336/17 is now withdrawn; CySEC announced the withdrawal on 5 June 2026 following a 22 December 2025 board decision, after KNF recorded a full licence suspension from 23 July 2025

Conotoxia Ltd is Cyprus company HE351239. CySEC's current former-firm record marks licence 336/17 Withdrawn. It is a distinct legal entity from Polish payment institution Conotoxia sp. z o.o., from Cinkciarz.pl entities, and from Conotoxia Inc. in the United States; those payment/remittance registrations must not be represented as investment-firm licences for the reviewed CFD service.

The main strengths are historically, Conotoxia published unusually detailed product, platform, leverage, safeguarding and bank-transfer information, including MT5/cTrader, 5000+ CFDs, segregated accounts, negative-balance protection and ICF membership while it was a CIF.

For active comparison purposes, the most important concrete advantages are Retained first-party pages describe low spreads/markups, zero Conotoxia commission on bank-transfer and Conotoxia Pay funding/withdrawals, and zero long-position swap on certain Single Stock/Single ETF CFDs. These are historical service specifications, not current executable pricing after licence withdrawal. and The retained site documents MetaTrader 5 and cTrader, including algorithmic robots/cBots and thousands of CFD instruments. Those pages are still online but cannot be treated as proof that Conotoxia Ltd may currently provide investment services..

The main drawbacks are the decisive issue is regulatory status: licence 336/17 is withdrawn after a full suspension from July 2025. The public Conotoxia Invest website still contains 'open account' and old 'regulated by CySEC' wording, so visitors could mistake stale pages for current authorisation unless the regulator record is checked..

A prospective client should also account for jurisdiction differences: No new Conotoxia Ltd CFD/forex onboarding should be inferred in Cyprus, Poland, Belgium or elsewhere from old passporting/marketing pages. The licence is withdrawn; the Polish KNF record says services could not be provided during the preceding full suspension. Belgian leveraged-OTC restrictions also remain independently relevant.

No current 2026 trading promotion is treated as valid because the investment-firm licence has been withdrawn. Any legacy campaign page must be considered historical unless a lawfully authorised successor entity is independently verified.

Key 2026 highlights include Conotoxia Ltd HE351239; CySEC 336/17 Withdrawn; full suspension from 23 July 2025; withdrawal announced 5 June 2026; legacy 5000+ CFDs; MT5 and cTrader; historical retail leverage up to 1:30; historical ICF, segregation and negative-balance protection. These are more useful than marketing slogans because they directly affect pricing, market access, platform capability or client protection.

Conotoxia Ltd was founded in 2017 and operated from Limassol, Cyprus. CySEC currently lists Chrysorroiatissis 11, 3032 Limassol for the withdrawn investment firm.

Yes, Conotoxia Invest is an established legitimate financial-services provider. Authoritative regulator evidence now overrides the retained broker marketing pages: CySEC lists the licence as Withdrawn and KNF records the earlier full suspension. The clear conflict between current regulator status and stale onboarding/licence wording materially reduces the review score and requires a no-account CTA.

That does not make every account equally protected; No new Conotoxia Ltd CFD/forex onboarding should be inferred in Cyprus, Poland, Belgium or elsewhere from old passporting/marketing pages. The licence is withdrawn; the Polish KNF record says services could not be provided during the preceding full suspension. Belgian leveraged-OTC restrictions also remain independently relevant.

Conotoxia Ltd held CySEC CIF licence 336/17, now Withdrawn. CySEC's decision archive records announcement on 5 June 2026 and board decision on 22 December 2025. KNF records that the licence had already been fully suspended from 23 July 2025, during which the entity could not provide investment services.

The retained Conotoxia site lists 'Rising Star of the Year' (Invest Cuffs 2021) and 'Best Trading Experience' (UltimateFintech 2022). They are historical awards and have no bearing on the current withdrawn-licence status or rating.

historically a Cyprus investment firm dealing in OTC CFDs, including dealing on own account according to the former CySEC permission set. It is now a closed/status profile for the withdrawn Conotoxia Ltd investment service, not a current broker recommendation.

CySEC currently records support@cy.conotoxia.com and +357 25 030 084 for Conotoxia Ltd. The retained site lists a separate +357 25030046 contact number. These channels may be relevant to legacy client matters but are not evidence of active onboarding.

Limassol, Cyprus for Conotoxia Ltd; the current CySEC former-firm record gives Chrysorroiatissis 11, 3032 Limassol.

Legacy Conotoxia pages retain contact/support routes. They should be used only for residual/legacy account questions unless Conotoxia publishes a newly authorised investment-service entity and regulator record.

The retained Trading Universe includes research, market commentary, an economic calendar and educational material. These resources may remain accessible, but they do not restore authority to provide investment services.

No current trading account exists under licence 336/17. Historical platform functionality should not be used to infer an active hedging policy after the withdrawal.

Unavailable for new Conotoxia Ltd investment-service onboarding under the withdrawn licence. Historical country notifications/EEA marketing do not create current eligibility.

Conotoxia Invest is best suited to former clients or researchers who need a factual record of the Conotoxia Ltd regulatory status and historical platform/product terms

Conotoxia Invest is a weaker fit for anyone seeking a new forex/CFD account; the underlying CySEC licence is withdrawn

No current rebate or fee discount is treated as actionable for the withdrawn investment service. Historical fee advantages are preserved only for context.

The retained site describes a single Smart Account giving access to 5000+ CFDs and Investment Advice, with Retail, Professional and Experienced Retail classifications. These are historical account specifications; no new Smart Account investment-service onboarding is treated as valid after withdrawal.

To open a live account, Not available through Conotoxia Ltd under licence 336/17. Although old pages still display sign-up language, CySEC now marks the licence Withdrawn and KNF records that investment services were already prohibited during the earlier full suspension. The broker must complete identity, residency and suitability/appropriateness checks before regulated products are enabled.

The retained site advertises a fast cTrader web/mobile demo and platform testing. Demo availability is not equivalent to legal live-account availability and does not change the withdrawn licence status.

Conotoxia Invest is not a proprietary-trading challenge, so there are no 'trading objectives' whose breach automatically terminates a funded challenge. Normal account restrictions instead come from margin rules, product permissions, suitability checks and the client agreement.

While authorised, Conotoxia's retained regulation page stated segregated client accounts, retail negative-balance protection and membership of the Cyprus Investor Compensation Fund. These are historical licensed-service protections; this review does not claim that a withdrawn firm offers new-client ICF/NBP protection.

The historical funding page required withdrawals to a bank account belonging to the same user and allowed extra-document requests, reflecting AML/payment-owner controls. No new KYC onboarding is treated as active.

Historical pages describe bank transfer and Conotoxia Pay/currency-wallet routes. Conotoxia said it charged no processing fee on specified bank transfers, while intermediary/mBank fees could apply. These pages are retained for legacy context, not a reason to send new trading funds.

No current new-account funding route is recognised after withdrawal of licence 336/17. Historical pages may still render deposit options and should not override the regulator status.

No current minimum deposit is applicable because the investment service is not open under the withdrawn licence. The retained Investment Advice page's 'no minimum entry threshold' wording concerned advice and should not be misrepresented as a current CFD account minimum.

Historically, withdrawals were made by bank transfer to a same-name account, with PLN and EUR/USD/GBP routes documented. Internet payment providers such as PayPal were explicitly not supported for withdrawal on the retained page.

For legacy balances/issues, use official Conotoxia/CySEC contact channels. The historical page said withdrawal requests were processed 08:00–16:00 CET business days and bank wires usually arrived in 1–5 working days, with longer times possible when documents were requested.

No fixed payout applies. The current concern is residual client asset handling under a withdrawn licence, not prospective trading returns.

Historical pages advertised zero Conotoxia processing fees on specified bank transfers/Conotoxia Pay and no commission on some CFDs, with spreads/markups and swaps depending on instrument. No 2026 actionable trading-fee schedule is claimed because investment services are no longer authorised.

Historically the Smart Account offered 5000+ CFDs across forex, ETFs, stocks, futures, indices, metals, energies and crypto. These instrument pages remain online but are explicitly treated as legacy service specifications.

Historical MetaTrader 5 and cTrader. The retained site also describes mobile access and algorithmic tooling. No platform is presented as an available new Conotoxia live-account route in 2026.

The retained instrument page claims 100+ Forex CFDs, 140+ Crypto CFDs and 5000+ total CFDs. Counts are historical and not evidence of current legal availability.

No current live-trading server is asserted because the investment licence is withdrawn. Historical MT5/cTrader connection details are not published here as an onboarding instruction.

A complete current set of trading-account base currencies is irrelevant after withdrawal and was not re-verified as an active-service specification.

Historically 140+ Crypto CFDs were advertised 24/7 with breaks and minimum sizes from 0.01 on MT5/cTrader. That was derivative exposure, not spot-crypto custody, and it is not treated as currently available.

Historical retail maximums on the retained site included 1:30 for Forex CFDs, 1:20 for major indices/gold, 1:10 for other commodities/futures in relevant cases and 1:2 for crypto. These are legacy terms only.

The retained site differentiated Retail, Experienced Retail and Professional treatment, with higher leverage available only on request/qualification. No leverage change is available for a new account under the withdrawn licence.

The old site advertised low spreads/markups rather than one durable universal minimum. Any displayed spread table is historical because Conotoxia Ltd no longer has an active CIF licence.

No current MAM/PAMM onboarding service is verified, and no managed-account feature is treated as active after withdrawal.

Historical platform support included MT5 robots and cTrader cBots/custom indicators. That technical capability is preserved only as historical context.

No current first-party copy-trading service is verified for an authorised Conotoxia Ltd account, and no legacy social feature is presented as available after withdrawal.